Skip to main content

Hippo Holdings Inc.

For the period ended Dec 31, 2025. Filed Mar 5, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 5, 2026

HIPO$36.29+0.6%Stored close · as of Nov 10, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits

Consolidated Statements of Operations and Comprehensive Income (Loss)

Years Ended December 31,
202520242023
(in millions, except share and per share data)
Revenue:
Net earned premium$380.1$272.5$107.5
Commission income, net51.363.663.4
Service and fee income11.811.615.7
Net investment income25.424.423.1
Total revenue468.6372.1209.7
Expenses:
Losses and loss adjustment expenses229.9209.0181.7
Insurance related expenses131.388.879.1
Technology and development expenses32.530.747.0
Sales and marketing expenses33.551.280.1
General and administrative expenses67.170.779.6
Impairment and restructuring charges5.03.65.5
Gain on sale of business(95.0)(54.4)—
Interest and other (income) expense, net1.0(0.1)(0.8)
Total expenses405.3399.5472.2
Income (loss) before income taxes63.3(27.4)(262.5)
Income tax expense0.71.20.5
Net income (loss)$62.6$(28.6)$(263.0)
Net income attributable to noncontrolling interests, net of tax4.911.910.1
Net income (loss) attributable to Hippo$57.7$(40.5)$(273.1)
Other comprehensive income (loss):
Change in net unrealized gain on investments, net of tax4.50.24.1
Comprehensive income (loss) attributable to Hippo$62.2$(40.3)$(269.0)
Per share data:
Net income (loss) per share attributable to Hippo
Basic$2.28$(1.64)$(11.58)
Diluted$2.22$(1.64)$(11.58)
Weighted average common shares outstanding
Basic25,253,52024,699,91323,578,922
Diluted26,011,39124,699,91323,578,922
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.